Completed
Topics
An IOM committee will review the published literature to identify appropriate evaluation criteria for tests based on "omics" technologies (e.g. genomics, epigenomics, proteomics, metabolomics) that are used as predictors of clinical outcomes. The committee will recommend an evaluation process for determining when predictive tests based on omics technologies are fit for use as a basis for clinical trial design, including stratification of patients and response to therapy in clinical trials.
Events
Discover
Events
Right Now & Next Up
Stay in the loop with can’t-miss sessions, live events, and activities happening over the next two days.
NAS Building Guided Tours Available!
Participate in a one-hour guided tour of the historic National Academy of Sciences building, highlighting its distinctive architecture, renowned artwork, and the intersection of art, science, and culture.